BMO Capital Upgrades Halozyme Therapeutics (HALO) to Outperform

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. TGT
2. MRK
3. BILL
4. MRNA
5. EL
6. RARE
7. LOW
8. DE
9. NTES
10. COTY

January 14, 2013 7:43 AM EST
Get Alerts HALO Hot Sheet
Price: $107.62 --0%

Rating Summary:
    15 Buy, 5 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 7 | Down: 10 | New: 19
Join SI Premium – FREE
BMO Capital upgraded Halozyme Therapeutics (NASDAQ: HALO) from Market Perform to Outperform with a price target of $12.00 (from $4.00).

For an analyst ratings summary and ratings history on Halozyme Therapeutics click here. For more ratings news on Halozyme Therapeutics click here.

Shares of Halozyme Therapeutics closed at $7.21 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Hot Upgrades, Upgrades

Related Entities

BMO Capital